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Abstract 
 
A striking characteristic of the highly successful techniques in molecular biology is that they are 
derived from natural occurring systems. RNA interference (RNAi), for example, utilises a 
mechanism that evolved in eukaryotes to destroy foreign nucleic acid. Other examples include 
restriction enzymes, the polymerase chain reaction, fluorescent proteins and CRISPR-Cas9. I 
propose that natural molecular mechanisms are exploited by biologists for their effectors’ 
(protein or nucleic acid) activity and biological specificity (protein or nucleic acid can cause 
precise reactions). I also show that the developmental trajectory of novel techniques in molecular 
biology, such as RNAi, is four characteristic phases. The first phase is discovery of a biological 
phenomenon. The second is identification of the mechanism’s trigger(s), the effector and 
biological specificity. The third is the application of the technique. The final phase is the 
maturation and refinement of the molecular biology technique. The development of new 
molecular biology techniques from nature is crucial for both biological and biomedical research. 
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Introduction 
 
Philosophy of science, with its emphasis on the structure of scientific theories, struggles to 
account for molecular biology (Darden 2006; Schaffner 1996). This area of biology is principally 
concerned with explaining the complex molecular phenomena underlying living processes by 
identifying the mechanisms that produce such processes (Tabery et al. 2015). In order to access 
the causal structure of molecular mechanisms it is necessary to manipulate the components of 
the mechanism and to observe the resulting effects with sophisticated molecular techniques. 
These techniques generate knowledge that cannot be obtained by any other means. Scientific 
knowledge in molecular biology is therefore acquired in a distinctive way compared to other 
areas of biology, progress is driven by the introduction and use of novel techniques. However, 
what drives the development of molecular biology techniques?  
 
In this paper, I firstly provide evidence that molecular biology techniques are derived by 
biologists from natural systems. In the second section, I identify that the natural systems’ strategy 
for technique development means biologists utilise the activity of a mechanism’s effector 
(protein or RNA) and exploit biological specificity (protein or nucleic acid can cause precise 
reactions). In the third section, I show that molecular biology technique development from 
nature can be separated into four phases and I present RNA interference (RNAi) as an exemplar 
case study. I conclude by discussing the implications of deriving techniques from nature for 
molecular biology. 
  
 
From natural systems to techniques 
 
A striking feature of the development of molecular biology techniques, which biologists 
themselves often highlight (for example, Lander 2016; Mello and Conte 2004), is that they are 
derived from natural occurring systems. These techniques are not developed through ‘rational 
design’, such as using engineering principles (discussed in O’Malley 2009) nor do they merely 
mimic nature (Ahn et al. 2015). In this paper I examine eight contemporary techniques that are 
derived from natural systems and are the most scientifically successful. These eight techniques 
have been patented, produced landmark scientific articles and been the subject of a Nobel prize 
(Ronai and Griffiths in press). The scientific community sees these techniques as significant 
advances. In chronological order these techniques are: restriction enzymes; DNA sequencing, 
polymerase chain reaction (PCR); gene targeting; fluorescent proteins (such as, green fluorescent 
protein); RNAi; induced pluripotent stem cells (iPS); and clustered regularly interspaced short 
palindromic repeats-CRISPR associated 9 (CRISPR-Cas9) (see Table 1). Throughout this paper I 
use RNAi as my detailed case study. This technique was chosen due to its contemporary history 
(see Fire et al. 1998), which means that it has not yet been examined to a great extent by 
philosophers and historians of biology. RNAi is a technique that introduces molecules of RNA 
into an organism in order to reduce the expression of a gene of interest (reviewed in, Mello and 
Conte 2004) (Figure 1). The eight molecular biology techniques are so ubiquitous that they are 
regarded as common knowledge by biologists. So when these techniques are mentioned in the 
Methods section of a scientific article, a citation to the technique is often not necessary. 
 
The eight molecular biology techniques discussed are derived from mechanisms that each 
evolved for a particular biological function in a natural system (see Table 1). The biological  
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Fig. 1: A model of the molecular biology technique of RNA interference (RNAi). (1) Double-
stranded RNA (dsRNA) is introduced into the experimental system. (2) The endogenous 
endonuclease Dicer cleaves the dsRNA into small fragments known as small interfering RNA 
(siRNA). (3) Or the siRNA is added directly into the experimental system. (4) The siRNA 
antisense strand attaches to the endogenous RNA-induced silencing complex (RISC), (5) which 
binds sequence specifically to the target mRNA. (6) RISC cuts the target mRNA which causes it 
to be degraded, therefore no gene function is executed.  
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Table 1: Summary and characterisation of eight highly successful molecular biology techniques. 
These techniques are all derived from natural systems and are now utilised as methodologies. For 
key references see Table 2. 
 
Technique (in 
chronological 
order of 
development) 
Originating 
natural 
system 
Biological 
function of 
mechanism 
Experimental 
context 
Type of effector  Type of biological 
specificity 
1. Restriction 
enzymes 
Bacteria Destroy foreign 
nucleic acid from 
bacteriophages 
In vitro Restriction 
endonuclease 
Stereochemical: DNA 
recognition sequence 
2. DNA 
sequencing 
Bacteria DNA replication In vitro DNA polymerase I Informational: 
dideoxynucleotides (also 
DNA primer) has 
sequence match to DNA 
template 
3. PCR Bacteria DNA replication In vitro DNA polymerase I Informational: DNA 
primers has sequence 
match to DNA template 
4. Gene 
targeting 
Organism or 
cell culture 
Homologous 
recombination 
Organisms & 
cell culture 
Endogenous 
endonuclease (for 
example, SPO11) 
Informational: 
exogenous DNA has 
sequence match to target 
DNA/gene 
5. Fluorescent 
proteins 
Jellyfish Unknown - 
emitted when 
jellyfish is 
agitated1 
Organisms & 
cell culture 
Fluorescent protein, 
in particular the 
flurophore 
Engineered 
informational specificity: 
fluorescent protein DNA 
placed in specific 
location 
6. RNAi Eukaryote or 
cell culture 
Destroy foreign 
nucleic acid or 
gene regulation 
Eukaryote 
organisms & 
cell culture 
Endogenous RNA-
induced silencing 
complex (RISC), in 
particular the 
Argonaute 
endonuclease 
Informational: dsRNA 
(& siRNA) with 
sequence match to target 
mRNA 
7. iPS Embryonic 
stem cells 
Stem cell function 
(unlimited self-
renewal & 
pluripotency) 
Cell culture Transcription 
factors (Oct4, Sox2, 
cMyc & Klf4)  
Stereochemical: DNA 
binding site  
8. CRISPR-Cas9 Bacteria Destroy foreign 
nucleic acid from 
bacteriophages 
Organisms & 
cell culture 
RNA-guided DNA 
endonuclease (cas9)  
Informational: guide 
RNA (crRNA + 
tracrRNA) with 
sequence match to target 
DNA 
 1(Davenport and Nicol 1955) 
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function of the RNAi mechanism, for example, is an eukaryotic defence system1 for the 
destruction of foreign nucleic acid and mobile elements (van Rij and Andino 2006; Waterhouse 
et al. 1998; Waterhouse et al. 2001). The same biological function, to destroy foreign nucleic acid 
in the organism, underlies the techniques of RNAi (derived from eukaryotes) and CRISPR-Cas9 
(derived from prokaryotes) (Bhaya et al. 2011; Wright et al. 2016), but the two techniques involve 
different molecular mechanisms (Table 1). The ‘arms race’ that occurs between viruses and their 
organismal hosts has provided biologists with the basis of two techniques. In contrast, green 
fluorescent protein was derived from a relatively unique biological phenomenon in jellyfish and 
is therefore taxonomically restricted.  
 
Natural systems show biologists what is mechanistically possible. Natural mechanisms have been 
selected by evolution and are likely to have a high level of effectiveness. However, the 
components of these mechanisms are contingent on historical, iterative events rather than being 
at an optimal state. Biologists can alter these components to reach an optimal state but are 
constrained by their possibility space. 
 
Biologists use molecular biology techniques developed from pre-existing, natural mechanisms 
because they can be ‘biologically normal interventions’ (Weber forthcoming). These techniques 
are compatible with living processes and do not create artificial phenomena. Furthermore, the 
use of a natural mechanism may allow the continuing function of the biological process (for 
example, fluorescent proteins) and cellular based techniques can be stably inherited in designed 
constructs with transgenerational effects. These techniques can be used to observe or intervene 
in active, complex biological processes even when no comprehensive understanding of these 
processes exists. 
 
 
The importance of natural systems for the development of 
techniques in molecular biology  
 
In this section I analyse why natural systems are used for the development of techniques in 
molecular biology. The techniques exploit two key components of natural mechanisms: an 
effector’s activity and the use of biological specificity. It is important to note that biologists 
implicitly recognise the importance of the effector’s activity and the use of biological specificity 
for molecular biology techniques2.  
 
  
Effector activity 
 
Living systems use effector molecules (such as, proteins or RNAs) to generate a particular 
activity within a mechanism. I have identified the protein effector, all from a natural system, for 
each of my eight molecular biology techniques (Table 1). The majority of the techniques utilise 
proteins that are catalytic enzymes (note, enzyme names normally end with '-ase') and the 
                                                 
1 The RNAi mechanism is thought to have been repurposed (Cerutti and Casas-Mollano 2006) for the precise 
regulation of endogenous gene expression, in particular for the regulation of developmental genes (Carrington and 
Ambros 2003). Therefore, the RNAi mechanism is a deeply entrenched process in eukaryotic organisms. 
2 For example, many studies on RNAi discuss the technique’s effector’s activity (Fellmann and Lowe 2014; 
Filipowicz et al. 2005; Li et al. 2006; Rana 2007; Siomi and Siomi 2009; Vaucheret et al. 1998) and specificity (Bartel 
2004; Elbashir et al. 2001b; Fellmann and Lowe 2014; Fire et al. 1998; Hamilton and Baulcombe 1999; Hammond et 
al. 2000; Hammond et al. 2001; Kennerdell and Carthew 1998; Parrish et al. 2000; Rana 2007; Siomi and Siomi 2009; 
Waterhouse et al. 1998; Waterhouse et al. 2001). 
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techniques leverage the efficiency of the enzymatic activity (Table 1). The two exceptions are the 
techniques of fluorescent proteins and iPS which utilise a protein’s stereochemistry, a flurophore 
or structural motif, respectively (Table 1).  
 
A technique’s effector is either endogenous or exogenous to the experimental system (Table 1). 
Endogenous based techniques use the effector for its original purpose but they appropriate the 
overall mechanism. For example, the effector of RNAi is the RNA-induced silencing complex 
(RISC), which is an endogenous component of a molecular mechanism present in all eukaryotes 
(Cerutti and Casas-Mollano 2006) (Figure 1). Whereas, exogenous based techniques use the 
effector for its original purpose but in another biological context. Therefore, the exogenous 
effector needs to be introduced into the experimental system and is more tractable than an 
endogenous effector. 
 
 
Biological specificity 
 
Living systems need biological specificity to achieve precise control over their molecular 
mechanisms (Griffiths et al. 2015; Waters 2007; Woodward 2010). In the eight molecular biology 
techniques studied here biologists introduce biological specificity into their experimental systems 
to precisely access the target mechanism with fine-grained control3. I have identified that the 
majority of the eight molecular biology techniques use nucleic acid sequence informational 
specificity (Griffiths and Stotz 2013), nucleic acid is the substrate of the mechanism (Table 1). 
For example, RNAi provides fine-grained control of gene expression because it uses nucleic acid 
sequence informational specificity (Figure 1). Before RNAi only a non-specific, permanent 
disruption in gene expression via mutagenesis was possible (Bellés 2010). One molecular biology 
technique, fluorescent proteins, uses what I term ‘engineered informational specificity’, where 
the biologist creates the specificity by placing the effector in a highly specific location. The last 
two molecular biology techniques, iPS and restriction enzymes, use protein stereochemical 
specificity (Griffiths and Stotz 2013) (Table 1).  
 
Informational and stereochemical specificity differ in an important aspect. For nucleic acid 
guided techniques the informational specificity is artificially designed whereas stereochemical 
specificity uses naturally derived specificity. Therefore, stereochemical specificity is fixed before 
the start of the experiment which means it is less programmable than informational specificity 
and not the preferred choice by biologists. 
 
 
The importance of an effector’s activity and biological specificity 
 
The effector activity and specificity of a technique are critical to its success. If there are multiple 
techniques available to achieve the same experimental purpose, then the one with the greatest 
efficiency or superior type of specificity is preferred by the scientific community. For example, 
transcription activator-like effector nucleases (TALENs)4 and zinc finger nucleases (ZFNs)5 are 
techniques used for the same experimental purpose as the CRISPR-Cas9 technique, DNA 
editing. However, a TALENs’ and ZFNs’ specificity is stereochemical so it needs to be 
reengineered for every experiment and are not as easily programmable for a wide range of targets 
                                                 
3 Biologists need interventions with minimal off-target events. Also, high specificity means that the technique can be 
‘multiplexed’ as multiple nucleic acid sites can be targeted at the same time. 
4 TALENs are a technique derived from the bacteria Xanthomonas (Boch et al. 2009; Moscou and Bogdanove 2009). 
5 ZFNs are a technique that uses two protein domains coupled together (Kim et al. 1996). 
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compared to CRISPR-Cas96. For this reason CRISPR-Cas9 became commercially viable and has 
replaced TALENs and ZFNs as the premier gene editing technique (Corbyn 2015; Doudna and 
Charpentier 2014). Therefore, the effector’s activity and specificity are likely to be critical for the 
commercialisation of the technique for widespread usage. 
 
 
Molecular biology technique development has four phases 
 
I propose that molecular biology techniques derived from natural systems have a specific pattern 
of development with four critical phases. These phases are: the discovery of a phenomenon; 
identification of the mechanism’s trigger(s); application of the technique; and maturation of the 
technique. Each of the eight molecular biology techniques show the four phases of technique 
development (see Table 2) and in this section I use the development of RNAi as a detailed case 
study. 
 
 
The first phase: discovery 
 
Biologists identify and describe an unusual phenomenon in a natural system. At this stage the 
underlying mechanism is not well characterised and the biological function of the mechanism is 
typically unknown. This phase can be identified by examining the studies that the application of 
the technique phase built upon. 
 
For example, in the early 1990s the RNAi7 phenomenon was first identified in plants (Table 2). 
Napoli et al. (1990); van der Krol et al. (1990) wanted to increase colour intensity in the Petunia 
hybrida flower. They introduced synthetic sense RNA into the plant in order to overexpress a 
gene in the pathway that controls formation of the flower pigment. Contrary to expectation, 
these flowers had less, rather than more, pigment. Therefore, the sense RNA had reduced the 
mRNA of the endogenous gene. During the 1990s multiple studies were conducted on how 
different organisms actively respond to the introduction of RNA (Fire et al. 1991; Guedes and 
Priess 1997; Guo and Kemphues 1995; Lin et al. 1995; Mello et al. 1996; Powell-Coffman et al. 
1996; Romano and Macino 1992). These early studies produced knowledge that was critical to 
the development of RNAi.  
 
 
The second phase: identification of the trigger(s) 
 
Biologists identify the specificity and effector8 component of the mechanism (see Table 3A&B). 
I term the specificity and effector ‘the trigger(s)’ because they are the key causative agents and are 
‘the causally specific actual difference maker’ under typical conditions (Carrier 2004; Waters 
2007; Woodward 2010). Once biologists identify the trigger(s) they can use it to precisely access  
                                                 
6 CRISPR-Cas is limited by the protospacer adjacent motif (PAM) but this sequence is dependent on the Cas being 
used (Doudna and Charpentier 2014). 
7 During the 1990s the RNAi phenomenon was described using many different terms. The initial study by Napoli et 
al. (1990) termed this phenomenon ‘co-suppression’ but a follow up study by Blokland et al. (1994) demonstrated 
that silencing occurred post-transcriptionally so it was referred to as ‘post transcriptional gene silencing’. Another 
study by Romano and Macino (1992) identified the RNAi phenomenon in a fungus, Neurospora crassa, and termed it 
‘quelling’. An early Caenorhabditis elegans study by Rocheleau et al. (1997) coined the term ‘RNA-mediated 
interference’. 
8 For techniques that have stereochemical specificity (Table 1) the effector is the specificity. 
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Table 2: The four phases of development for the eight highly successful molecular biology 
techniques. For each technique I identify the first paper that: discovered the phenomenon; 
identified the mechanism’s effector; identified the mechanism’s specificity applied the trigger(s); 
and any highly cited papers that demonstrate the maturation of the technique.  
 
Technique (in 
chronological 
order of 
development) 
Phase Reference Description 
1. Restriction 
enzymes 
Discovery Luria and Human 
(1952) 
Discovered that bacteriophage (T1, T2, T3, T4, T5, 
T6 and T7) vary in their ability to grow in different 
bacterial (Escherichia coli and Shigella dysenteriae) strains. 
Dussoix and Arber 
(1962) 
Discovered that bacteriophage λ DNA degrades in 
Escherichia coli strains. 
Identification of 
specificity/effector 
Kelly Jr and Smith 
(1970); Smith and 
Welcox (1970)1 
Identified the nucleotide recognition sequence that 
causes restriction enzymes (in particular, a type II 
which recognises DNA and cuts sites at the same 
place, endonuclease R from Hemophilus influenza) to 
cut DNA. 
Application of trigger Danna and 
Nathans (1971) 
Applied restriction enzyme (endonuclease R from 
Hemophilus influenza) to cut up DNA. 
Maturation Feinberg and 
Vogelstein (1983) 
Developed restriction enzymes using radiolabelling 
to efficiently recover DNA fragments. 
2. DNA 
sequencing 
Discovery Watson and Crick 
(1953) 
Discovered the complementary DNA structure in 
calf thymus (possibly) and proposed a mechanism for 
DNA replication. Also, predicted the existence of 
DNA polymerase. 
Matthaei et al. 
(1962) 
Discovered that three nucleotides code for a specific 
amino acid in a cell-free system of Escherichia coli. 
Also, predicted the code was universal. 
Identification of effector Kornberg et al. 
(1956b) 
Identified DNA polymerase in Escherichia coli. 
Identification of 
specificity 
Atkinson et al. 
(1969) 
Identified that dideoxynucleotides cause DNA 
polymerase to terminate synthesis of DNA.  
Application of triggers Sanger et al. (1977) Applied dideoxynucleotides with DNA polymerase 
from Escherichia coli to determine the DNA sequence 
of bacteriophage φX174. 
Maturation The C. elegans 
Sequencing 
Consortium (1998) 
Developed DNA (Sanger) sequencing to sequence 
the first multicellular organism (Caenorhabditis elegans) 
genome. 
International 
Human Genome 
Sequencing 
Consortium (2001) 
Developed DNA (Sanger) sequencing to sequence 
the human genome. 
3. PCR Discovery Watson and Crick 
(1953) 
Discovered the complementary DNA structure in 
calf thymus (possibly) and proposed a mechanism for 
DNA replication. Also, predicted the existence of 
DNA polymerase. 
Meselson and 
Stahl (1958) 
Discovered that DNA replicates semi-conservatively 
in Escherichia coli. 
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Identification of effector Kornberg et al. 
(1956b) 
Identified DNA polymerase in Escherichia coli. 
Identification of 
specificity 
Kornberg et al. 
(1956a) 
Identified that a primer causes DNA polymerase to 
initiate synthesis of DNA. 
Application of triggers2 Saiki et al. (1985) Applied primers with DNA polymerase from 
Escherichia coli to amplify DNA region. 
Maturation Saiki et al. (1988) Developed PCR to be thermostable using DNA 
polymerase from Thermus aquaticus. 
4. Gene targeting Discovery Gluzman et al. 
(1977); Vogel et al. 
(1977)1 
Discovered that a mutant phenotype can be rescued 
in a simian virus 40 (SV40) temperature-sensitive 
mutant (tsD202) when added to monkey CV1 cells 
(containing endogenous integrated SV40). Also, 
discovered that the rescue is due to recombination. 
Identification of 
specificity 
Hinnen et al. 
(1978) 
Identified that exogenous DNA of LEU2 causes site 
specific recombination with homologous 
chromosomal DNA in Saccharomyces cerevisiae. 
Application of trigger Smithies et al. 
(1985) 
Applied exogenous DNA to modify only the target 
gene (β-globin) in human cells. 
Maturation Thomas and 
Capecchi (1987) 
Developed gene targeting to inactivate an 
endogenous gene (hptr) in mouse embryonic stem 
cells.  
Doetschman et al. 
(1987) 
Developed gene targeting to correct mutant hptr in 
mouse embryonic stem cells. 
Mansour et al. 
(1988) 
Developed gene targeting selection (positive for cells 
that have incorporated exogenous DNA and negative 
for cells that have randomly incorporated exogenous 
DNA) in mouse embryonic stem cells. 
Identification of effector N/A3 Endogenous endonucleases create a double-stranded 
break and this initiates repair pathway. For example, 
SPO11. 
5. Fluorescent 
proteins 
Discovery Davenport and 
Nicol (1955) 
Discovered the green fluorescence in Aequorea victoria. 
Identification of effector Shimomura et al. 
(1962) 
Identified the green fluorescent protein (GFP) in 
Aequorea victoria. 
Identification of 
specificity 
Prasher et al. 
(1992) 
Identified the genomic DNA and cDNA sequence of 
GFP that causes fluorescence in Aequorea victoria. 
Application of trigger Chalfie et al. 
(1994) 
Applied GFP cDNA to generate fluorescence in E. 
coli and Caenorhabditis elegans cells. 
Maturation Heim et al. (1995) Developed GFP spectral characteristics using a point 
mutation in Escherichia coli. 
Cormack et al. 
(1996) 
Developed GFP variants that fluoresce more 
intensely in Escherichia coli. 
6. RNAi Discovery Napoli et al. 
(1990) 
Discovered the knockdown of chalcone synthase in 
Petunia hybrida. 
Identification of 
specificity (component) 
& application of trigger 
Fire et al. (1998) Identified that dsRNA causes sequence specific 
regulation of mRNA in Caenorhabditis elegans.  
Applied dsRNA to knockdown gene expression in 
Caenorhabditis elegans. 
Identification of 
specificity (processed 
component) 
Hamilton and 
Baulcombe (1999) 
Identified that siRNA (processed product of dsRNA) 
causes sequence specific regulation of mRNA in 
plants. 
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Identification of effector Hammond et al. 
(2000) 
Identified the RNA-induced silencing complex 
(RISC) which contains an endonuclease that cleaves 
target mRNA in Drosophila cells. 
Maturation Elbashir et al. 
(2001a) 
Developed RNAi to knockdown gene expression in 
mammalian and Drosophila cells. 
7. iPS Discovery Gurdon (1962) Discovered that cell differentiation is reversible 
because the nucleus of a somatic cell can successfully 
replace the nucleus of an egg cell in Xenopus laevis. 
Identification of 
specificity/effector & 
application of trigger 
Takahashi and 
Yamanaka (2006) 
Identified the genome and transcriptome changes 
that cause four transcription factors (Oct3/4, Sox2, 
c-Myc and Klf4 in mice) to make somatic cells 
become pluripotent stem cells.  
Applied the four transcription factors cDNA to 
reprogram embryonic and adult fibroblast mice cells. 
Maturation Takahashi et al. 
(2007) 
Developed iPS in human cells. 
8. CRISPR-Cas9 Discovery Ishino et al. (1987) Discovered the CRISPR motif (repeated sequence 
with spacers) in the DNA sequence of Escherichia coli. 
Identification of effector Makarova et al. 
(2002) 
Identified the CRISPR-associated (cas) genes in the 
genome sequences of bacteria and archaea. In 
particular, the class 2, Type II (recognises DNA and 
cleavage results in double-stranded break) Cas9 
(COG3513) in Streptococcus pyogenes, Campylobacter jejuni, 
Neisseria meningitidis and Pasteurella multocida. 
Identification of 
specificity (component 
A) 
Brouns et al. 
(2008) 
Identified that CRISPR RNAs (crRNAs) cause Cas9 
to sequence specifically cleave DNA in Escherichia coli. 
Identification of 
specificity (component 
B) & application of 
triggers 
Jinek et al. (2012) Identified that crRNA and trans-activating CRISPR 
RNA (tracrRNA) must complementary base pair to 
cause Cas9 to site-specifically cleave DNA. 
Applied a tracrRNA-crRNA complex (the ‘single-
guide RNA’) with Cas9 from Streptococcus pyogenes to 
cleave DNA. 
Maturation Cong et al. (2013) Developed CRISPR-Cas9 to edit the genome of 
mammalian (human and mouse) cells. 
Mali et al. (2013) 
1 This paper was published in two parts. 
2 Kleppe et al. (1971) only applied primers with DNA polymerase to replicate short synthetic 
DNA rather than amplify a DNA region. 
3 A single study cannot be identified because the biological mechanism underlying gene targeting 
has multiple effectors.  
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Table 3: The key experiments for the RNAi technique conducted by Fire et al. (1998). 
Experiments that (A) identified the triggers in the RNAi mechanism; and (B) identified the target 
of the specificity in the RNAi mechanism. 
 
(A) 
Specificity Range tested Result 
Non-purified single-
stranded RNA 
(ssRNA) 
Sense RNA or antisense RNA When non-purified ssRNA was introduced into the experimental 
system caused RNAi.  
Purified ssRNA Sense RNA or antisense RNA Purified ssRNA led to weaker RNAi compared to purified dsRNA, 
indicated that dsRNA causes RNAi. 
Complementary sense 
and antisense strand 
RNA 
Pre-annealed; injected 
sequentially; or injected 
sequentially but with long time 
interval between RNAs 
Pre-annealing of RNA led to stronger RNAi, indicated that the 
formation of dsRNA was important for RNAi. 
Sequential injection of sense and antisense RNA led to RNAi, 
indicated that RNA strands could hybridise to form dsRNA in the 
experimental system. 
If there was a long time interval between sequential injection of 
RNAs no RNAi occurred, indicated that over time ssRNA are 
degraded or become inaccessible in the experimental system.  
Time post-injection 
of RNA 
6; 15; 27; 41; or 56 hours When there was a long time interval after RNA was introduced into 
the experimental system RNAi decreased. 
ssRNA and control 
gene dsRNA 
ssRNA not attached to dsRNA; 
ssRNA attached at its 5’ end to 
dsRNA; or ssRNA attached at 
its 3’ end to dsRNA 
For the gene that the ssRNA targeted no RNAi occurred, indicated 
that sequence specificity not double stranded structure was 
important for RNAi. 
dsRNA length 299 to 1033 nucleotides Nucleotide length of dsRNA did not affect RNAi.  
RNA dosage 30,000 to 3,600,000 RNA 
molecules per organism 
Very low dsRNA dosages triggered RNAi, indicated that RNAi is a 
catalytic process (i.e. enzymes involved) otherwise there would be 
not enough RNA molecules to bind to all the endogenous mRNA in 
the experimental system.  
Site of injection of 
RNA in organism 
Body cavity of head; body 
cavity of tail; or gonad 
In tissues other than the ones injected RNAi occurred, indicated that 
RNAi is systemic. Also, injection of adults sometimes led to 
offspring with RNAi, indicated that trans-generational inheritance of 
RNAi occurred. These results suggested that the RNAi mechanism 
existed throughout the whole organism. 
 
(B) 
Target of specificity Range tested Result 
Gene regions One exon, 
multiple exons; 
intron; or 
promoter 
RNAi occurred only when the coding sequence of the mRNA was targeted, 
indicated that RNAi works through post-transcriptional regulation.  
Conserved gene 
segment 
 RNAi led to an unexpected phenotype, indicated that RNAi affects genes with a 
similar sequence to the gene of interest. 
Gene of interest unc-22; unc-54; fem-
1; hlh-1 ;gfp; or 
mex-3 
The target of RNAi was genes that are non-essential and have previously been 
characterised with an easily identifiable visual phenotype. Also, the relationship 
between the gene’s expression and phenotype was in the manipulable direction 
(i.e. reduced expression increased the severity of the phenotype). 
Transgenic line 
expressing two GFP 
reporter proteins 
 RNAi occurred in individual cells of the organism. 
mex-3 in an in situ 
hybridisation 
experiment 
 The target of RNAi was a gene that is abundant in early embryos (a useful 
developmental period for an in situ experiment). Endogenous mRNA disappeared 
suggesting it was destroyed, visually indicated that mRNA (not precursor mRNA 
nor protein) was the target of RNAi. 
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the causal structure of the mechanism. If the effector is endogenous to the experimental system 
(Table 1), then it does not need to be added to the experiment and its identification is not 
essential for the development of the technique. 
 
For example, in the late 1990s dsRNA was found to be causally specific for the RNAi 
mechanism (Table 2). The dsRNA was investigated due to it being accidently produced in earlier 
experiments as it was found that:  
… polymerases, although highly specific, produce some random or ectopic transcripts. 
DNA transgene arrays also produce a fraction of aberrant RNA products3… we 
surmised that the interfering RNA populations might include some molecules with 
double-stranded character. (Fire et al. 1998, p. 807) 
Fire et al. (1998) tested the specificity of RNA molecules to control the RNAi mechanism in C. 
elegans (Table 3A). The dsRNA was identified as the cause of sequence specific regulation of 
mRNA. Fire et al. (1998, p. 806):  
… investigate[d] the requirements for structure and delivery of the interfering RNA. To 
our surprise, we found that double-stranded RNA was substantially more effective at 
producing interference than was either strand individually. 
Therefore, the study was a conclusive demonstration of how dsRNA can be used to control the 
RNAi mechanism. 
 
Biologists then wondered how dsRNA could bind to the mRNA to sequence specifically cleave 
it. They found that dsRNA is processed into small RNA fragments (antisense and sense) in many 
different organisms and suggested that these were necessary for RNAi (Hamilton and 
Baulcombe 1999; Hammond et al. 2000; Parrish et al. 2000; Zamore et al. 2000). The small 
interfering RNAs (siRNA), 21-23 nucleotides in length, were shown to sequence specifically 
guide the cleavage of the mRNA (Elbashir et al. 2001b) (Table 2). 
 
Two years after the RNAi technique was developed the endogenous effector component that 
degrades the target mRNA was identified as the RNA-induced silencing complex (RISC) (Figure 
1, Table 2). The endonuclease that cuts the target mRNA sequence-specifically was identified in 
Drosophila cells as Argonaute, which is part of RISC (Hammond et al. 2000; Martinez et al. 2002). 
The effector that cleaves dsRNA into siRNAs was identified as a ribonuclease type III named 
Dicer (Bernstein et al. 2001). Biologists then pursued the mechanistic details such as the 
functions of different forms of Argonaute (Rana 2007).  
 
 
The third phase: application of the trigger(s) 
 
Biologists conclusively determine that when the trigger(s) is introduced into the experimental 
system it achieves some intended effect on the target of the specificity. The trigger(s) is exploited 
in three types of investigative strategies: to manipulate an effector’s activity in a non-cellular 
experimental system (for example, restriction enzymes); to intervene on a cellular experimental 
system (for example, RNAi); or as a tracer to follow a biological process9 (for example, 
fluorescent proteins) (Table 1). At this stage a deep understanding of the mechanism underlying 
the technique is not necessary for the technique to work. 
 
For example, the RNAi technique was first applied in the Fire et al. (1998) paper ‘Potent and 
specific genetic interference by double-stranded RNA in Caenorhabditis elegans’ published in the 
journal Nature (Table 2). The study was a conclusive demonstration of how dsRNA can be 
                                                 
9 For an in depth discussion see (Griesemer 2007). 
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applied as a molecular biology technique to manipulate gene expression in C. elegans. Fire et al. 
(1998, p. 810) concluded that RNAi: 
… adds to the tools available for studying gene function in C. elegans. In particular, it 
should now be possible functionally to analyse many interesting coding regions21 for 
which no specific function has been defined. 
Interestingly, Fire et al. (1998, p. 810) explicitly stated that they did not understand the biological 
function of the RNAi mechanism:  
Whatever their target, the mechanisms underlying RNA interference probably exist for a 
biological purpose. 
 
It is important to note that when a molecular biology technique is developed for an organismal 
experimental context (Table 1) it is first tested in a ‘model organism’ system. For example, RNAi 
was first developed using the model organism C. elegans (Fire et al. 1998). Model organisms 
provide standardised experimental systems that are relatively well characterised at the molecular 
level act as a prototype for technique development (Ankeny 2000; Leonelli and Ankeny 2013). 
When a technique has been validated in a model organism there is the expectation that, due to 
the fundamental unity of living systems, it might be applied to other organisms. The use of 
model organisms is particularly important given the complexity and cost of molecular biology 
experiments. 
 
 
The fourth phase: maturation 
 
Once the technique is established biologists improve and expand its performance. The scientific 
community invests considerable research activity into characterising, both spatially and 
temporally, the mechanism in natural systems. Therefore, the technique generates further 
research on the mechanism that underlies it. The new knowledge acquired may improve access 
to the mechanism or allow the technique to be better controlled, enabling the technique to 
continue to be refined and standardised. 
 
Immediately following Fire et al. (1998), RNAi was shown to work in multiple organisms10 
(Table 2). In mammals RNAi (using dsRNA) initially failed due to the immune response elicited, 
however, when siRNAs were used gene expression could be altered (Elbashir et al. 2001a). RNAi 
has become a highly selective molecular biology technique for reducing expression of a target 
gene and today it is widely used for both basic and applied research (Deng et al. 2014; Fellmann 
and Lowe 2014; Mello and Conte 2004). To this day the mechanism of RNAi is still being 
investigated. 
 
 
Molecular biology technique development 
 
The four phases are necessary features of technique development when derived from a natural 
system. I have shown that eight highly successful molecular biology techniques have these four 
phases of development (Table 2), additional techniques include: reverse transcription; molecular 
cloning; monoclonal antibodies; site directed mutagenesis; and immunotherapy. Future research 
                                                 
10 The RNAi technique was used in C. elegans (Fitzgerald and Schwarzbauer 1998; Montgomery et al. 1998; Ogg and 
Ruvkun 1998; Page and Winter 1998; Skop and White 1998; Tabuse et al. 1998; Timmons and Fire 1998); two 
species of plants, Nicotiana tabaccum and Oryza sativa (Waterhouse et al. 1998); and D. melanogaster (Kennerdell and 
Carthew 1998). 
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will be able to show that these techniques also have the four phases of development and identify 
these techniques’ effector’s activity and specificity. 
 
The development of new molecular biology techniques accelerates research and generates new 
scientific knowledge that would otherwise not exist. A new technique can help uncover 
previously undetected phenomena and paradoxically, in turn lead to the development of yet 
another technique. For example, restriction enzymes were instrumental to the initial detection of 
the RNAi phenomena (Napoli et al. 1990; van der Krol et al. 1990) and during the application 
phase of development for RNAi green fluorescent protein was used to visualise that the RNAi 
mechanism occurs within the cell (Table 3B, Fire et al. 1998). Therefore, the techniques in 
molecular biology build upon one another and are cumulative.  
 
 
Cognitive values and the success of the techniques 
 
Cognitive values11 play an important role in the assessment of theory change in the sciences 
(Darden 1991; Douglas 2013; Kuhn 1977). Here I identify three cognitive values that are 
important for the scientific community’s adoption of a technique. First, the technique needs to 
be fruitful for further research. Techniques need to generate new knowledge and open up areas 
of research that were previously unimaginable. For example, RNAi has helped biologists 
manipulate RNA thus leading to a more sophisticated understanding of the function of RNA 
(Mello and Conte 2004) and this has allowed biologists to manipulate genes that are lethal in 
development in order to investigate their functions (for example, Fitzgerald and Schwarzbauer 
1998). Second, the technique should allow expansion of its scope of application far beyond its 
original biological context. After the effector protein is identified it must either be endogenous to 
the experimental system (and also conserved in the taxa that will be the experimental system) or 
be exogenous and able to operate in a range of experimental systems. A technique that has 
applications in many contexts means a larger scientific community can use the technique. In 
addition, a technique that can be used in mammals is particularly desired due to the value placed 
on medical and therapeutic research. For example, the RNAi effector, RISC, is present in all 
eukaryotes (Cerutti and Casas-Mollano 2006) and RNAi can be used in human cell lines 
(Elbashir et al. 2001a). Third, the technique needs to have extendability. The technique should 
accommodate modifications so that it can be used for different or expanded capabilities. 
Therefore, a technique can become the progenitor for a family of related techniques. For 
example, a form of RNAi was developed that used RNA molecules targeted at promoters to 
increase rather than decrease gene expression (Li et al. 2006). It is important to note that whether 
a technique rates highly on these three cognitive values it can only be identified in hindsight as 
that judgment is based on the employment of the technique (Darden 1991; Douglas 2013). The 
three cognitive values I have identified do not compete with one another as similar theoretical 
values do (Darden 1991) - a technique can be fruitful, have broad scope and be extendable at the 
same time.  
 
 
Conclusions 
 
A deeper understanding of the characteristics of natural systems and the development of 
scientific practice is gained by examining how molecular biology techniques are developed by 
biologists. In this paper I have investigated eight highly successful techniques of contemporary 
molecular biology that are derived from natural systems. I have argued that the development of 
                                                 
11 Otherwise referred to as epistemic values (Douglas 2013). 
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these techniques falls into four phases. What are the implications of the fact that biologists 
develop molecular biology techniques from natural systems? Biologists’ knowledge about natural 
systems limits what can be developed as a technique. Molecular biology techniques, and 
therefore molecular biology knowledge, are contingent. If biologists had discovered different 
phenomena in natural systems in the past then different techniques would have been developed. 
Molecular biology knowledge would have been altogether different, although we might speculate 
that deeply entrenched biological processes that are highly conserved across taxa (for example, 
the RNAi mechanism) will always be discovered. 
 
It is an open question whether molecular biology will continue to progress through the 
development of molecular techniques derived from natural systems. Perhaps knowledge 
construction in molecular biology requires a natural systems strategy. Alternatively, as a relatively 
immature science that is still discovering its fundamental phenomena, adopting this strategy 
could be just an immature stage for molecular biology. There is some evidence that biologists 
working on synthetic biology have started to use rational design in organisms, for example, the 
high profile ‘Human Genome Project–Write’ (Boeke et al. 2016). However, biologists often find 
that rational design is laborious and that selection methods lead to improved technique 
development and outcomes (Silverman 2003). Furthermore, a rational design strategy cannot be 
used to access the causal structure of molecular mechanisms when no comprehensive 
understanding of these mechanisms exists. 
 
What makes molecular biology such a unique area of the biological sciences is perhaps the fact 
that its scientific practice is based on a collection of research tools (Burian 1993). I therefore 
suggest that molecular biology is a historically accumulated set of techniques to manipulate, 
intervene on, and trace biological processes. Further, a biologist’s explanation of a molecular 
mechanism is dependent upon the molecular biology techniques they use to investigate the 
mechanism (Trujillo et al. 2015). In molecular biology, even more than in other areas of science, 
the development of technological capabilities and scientific knowledge are inextricably linked.  
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